Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
Portfolio Pulse from
Mesoblast Limited announced that pricing information for its product Ryoncil® is now available in all four major drug pricing compendia in the United States. This inclusion provides essential details for ordering the product, including manufacturing details, National Drug Codes, and pricing.
March 14, 2025 | 12:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mesoblast Limited's Ryoncil® is now listed in all major US drug pricing compendia, facilitating easier access to pricing and ordering information.
The inclusion of Ryoncil® in all major US drug pricing compendia is a significant step for Mesoblast, as it enhances the product's visibility and accessibility to healthcare providers. This could potentially lead to increased sales and market penetration, positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90